AdvaMed today released a report cautioning about a “future at risk” in medtech, warning that a lack of startups and shrinking venture capital funds could compromise the industry as a whole.
The medtech advocacy group also included a number of solutions and was optimistic about the future, noting shortened time-to-approval for new devices through the FDA and policy wins, such as the suspension of the medical device tax.
